The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,263,492 in first-year total cost, median $479,100.
Most frequent study sections
- Special Emphasis Panel[ZRG1 MGG-M (70)]5
Most frequent institutions
- ST. JUDE CHILDREN'S RESEARCH HOSPITAL2
- UNIVERSITY OF CALIFORNIA BERKELEY1
- UNIVERSITY OF WASHINGTON1
- WASHINGTON UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | A Modality-Agnostic Potency Assay Enabling Both Ex Vivo and In Vivo Genome Editing Therapeutics for Sickle Cell Disease1U01AI176469-01 | GIANNIKOPOULOS, PETROSGURKAN, UMUT A. | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $489,542 | ZRG1 |
| 2023 | Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs1U01AI176470-01 | TSAI, SHENGDAR | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $479,100 | ZRG1 |
| 2023 | Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs1U01AI176471-01 | TSAI, SHENGDAR | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $479,100 | ZRG1 |
| 2023 | Genome sequencing for evaluating the efficacy, specificity, and safety of human genome editing1U01AI176465-01 | DUNCAVAGE, ERIC JSPENCER, DAVID H | WASHINGTON UNIVERSITY, MO | $464,025 | ZRG1 |
| 2023 | Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics1U01AI176460-01 | FREEDMAN, BENJAMIN SOLOMON | UNIVERSITY OF WASHINGTON, WA | $351,725 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.